Dr Elisabetta Patorno (Brigham Women's Hospital, Boston, US) discusses the EMPRISE Study - Empagliflozin and the risk of HF hospitalisation in routine clinical care - A first analysis.
Filmed by Radcliffe Cardiology on site at ACC 2019.
This interview was supported by an unrestricted educational grant from Boehringer-Ingelheim
Videographer: Josh Birch
Interviewer: Liam O'Neill